Status:
COMPLETED
Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs
Lead Sponsor:
Center for Epidemiology and Health Research, Germany
Collaborating Sponsors:
Bayer
Conditions:
Breast Cancer
Eligibility:
FEMALE
Up to 50 years
Brief Summary
The objective of this study is to determine the breast cancer risk of Mirena® users compared to copper intrauterine device (IUD) users in a community-based case-control study.
Detailed Description
This is a community-based case-control study in Germany and Finland. Cases will be identified from cancer registries, tumor centers and breast centers. Matched controls will be accrued from the same r...
Eligibility Criteria
Inclusion
- cases: women with a breast cancer who are younger than 50 years of age at cancer diagnosis
- controls: women without a breast cancer diagnosis who are younger than 50 years at the time of the interview
Exclusion
- women who are not willing to participate
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
25565 Patients enrolled
Trial Details
Trial ID
NCT00461253
Start Date
October 1 2006
End Date
March 1 2014
Last Update
January 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Epidemiology and Health Research
Berlin, Germany, 10115